SGS and Pall Life Sciences Experts Join Pharma Asia’s Editorial Advisory Board
Dated: 6/1/2008
Eize de Boer (PhD), global manager for Life Science Auditing at SGS, and Jerold Martin (MSc), senior vice president, Scientific Affairs for Pall Life Sciences, join Pharma Asia as editorial advisors.
Since joining SGS in 2007, Dr. de Boer has been helping drug manufacturers and suppliers handle the volume, complexity and breadth of today’s regulatory environment in a globally consistent manner while reducing risk, increasing safety and ensuring sustainable business practices.
He oversees the creation and project management of second- and third-party auditing programs to support SGS’ quality management offering for the pharmaceutical industry. Previously, Dr. de Boer served as site director for Wyeth, which he joined in 1997. He was responsible for manufacturing and supply chain operations, including the development and maintenance of a wide variety of pharmaceutical quality management systems. He holds a PhD in biochemistry from the University of Amsterdam, The Netherlands.
At Pall Life Sciences, Martin is responsible for technical and regulatory communications. He has over 30 years experience in biopharmaceutical filtration and separation technologies including validation, technical services, research and development, and marketing.
Martin is director and technology committee chair with the BioProcess Systems Alliance (BPSA), where he has recently co-authored the BPSA Guides to Component Quality Tests, Irradiation and Sterilization, and Extractables and Leachables from Single-use Systems for biomanufacturing. He is on advisory boards of Parenteral Drug Association (PDA) and magazines such as Genetic Engineering News and Pharmaceutical Technology Europe. He holds an MSc in Microbiology from the University of Toronto.
